<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1561-3194</journal-id>
<journal-title><![CDATA[Revista de Ciencias Médicas de Pinar del Río]]></journal-title>
<abbrev-journal-title><![CDATA[Rev Ciencias Médicas]]></abbrev-journal-title>
<issn>1561-3194</issn>
<publisher>
<publisher-name><![CDATA[Editorial Ciencias Médicas]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1561-31942020000100037</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Mieloma múltiple en pacientes hospitalizados en hospital provincial pinareño]]></article-title>
<article-title xml:lang="en"><![CDATA[Multiple myeloma in patients admitted the provincial hospital of Pinar del Río]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Ordoñez Alvarez]]></surname>
<given-names><![CDATA[Lázaro Yoan]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Díaz Alfonso]]></surname>
<given-names><![CDATA[Humbelina]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Hernández Gálvez]]></surname>
<given-names><![CDATA[Juan Carlos]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Junco Labrador]]></surname>
<given-names><![CDATA[Liyanis]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Hernández Castro]]></surname>
<given-names><![CDATA[Juana María]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad de Ciencias Médicas de Pinar del Río Policlínico Universitario Hermanos Cruz ]]></institution>
<addr-line><![CDATA[Pinar del Río ]]></addr-line>
<country>Cuba</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Universidad de Ciencias Médicas de Pinar del Río Hospital Clínico Quirúrgico Docente Dr. León Cuervo Rubio ]]></institution>
<addr-line><![CDATA[Pinar del Río ]]></addr-line>
<country>Cuba</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>02</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>02</month>
<year>2020</year>
</pub-date>
<volume>24</volume>
<numero>1</numero>
<fpage>37</fpage>
<lpage>44</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_arttext&amp;pid=S1561-31942020000100037&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_abstract&amp;pid=S1561-31942020000100037&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_pdf&amp;pid=S1561-31942020000100037&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN  Introducción:  el mieloma múltiple es un tumor derivado de las células plasmáticas, un tipo de células sanguíneas situadas en la médula ósea que se encargan de producir anticuerpos que sirven para combatir los gérmenes.  Objetivo:  describir el comportamiento clínico epidemiológico del mieloma múltiple, en pacientes hospitalizados en los servicios de Medicina Interna y Geriatría del Hospital Clínico Quirúrgico Docente Dr. León Cuervo Rubio de Pinar del Río, durante los años 2017 y 2018.  Métodos:  se realizó un estudio observacional, descriptivo, longitudinal y prospectivo. El universo estuvo conformado por 31 pacientes con diagnóstico de mieloma múltiple, la muestra se conformó por 25 pacientes mediante un muestreo simple aleatorio. Resultados: se observó predominio de la enfermedad en los pacientes masculinos y de los grupos de edades de 70-79 años, se obtuvo como principales comorbilidades y complicaciones la anemia y la insuficiencia renal.  Conclusiones:  es importante el conocimiento del comportamiento clínico epidemiológico del mieloma múltiple para un diagnóstico oportuno e integral y el mejoramiento de la calidad de vida del paciente.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[ABSTRACT  Introduction:  multiple myeloma is a tumor derived from plasma cells, a type of blood cell in the bone marrow that produces antibodies to fight the germs.  Objective:  to describe the clinical epidemiological behavior of multiple myeloma in patients hospitalized in the Internal Medicine and Geriatrics services at Dr. León Cuervo Rubio Clinical Surgical Teaching Hospital during the years 2017 and 2018, in Pinar del Río.  Methods:  an observational, descriptive, longitudinal and prospective study was conducted. The target group included 31 patients diagnosed with multiple myeloma; the sample comprised 25 patients by simple random sample.  Results:  a prevalence of the disease was observed in male patients and in the age group from 70-79 years old. The main comorbidities and complications presented by patients with multiple myeloma were anemia in all of them, and kidney failure.  Conclusions:  knowledge of the clinical epidemiological behavior of multiple myeloma is important in order to achieve a timely and comprehensive diagnosis to improve the patient&#8217;s quality of life.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[MIELOMA MÚLTIPLE]]></kwd>
<kwd lng="es"><![CDATA[NEOPLASIA]]></kwd>
<kwd lng="es"><![CDATA[CÉLULAS PLASMÁTICAS]]></kwd>
<kwd lng="es"><![CDATA[CÉLULAS SANGUÍNEAS]]></kwd>
<kwd lng="es"><![CDATA[MÉDULA ÓSEA]]></kwd>
<kwd lng="en"><![CDATA[MULTIPLE MYELOMA]]></kwd>
<kwd lng="en"><![CDATA[NEOPLASMS]]></kwd>
<kwd lng="en"><![CDATA[PLASMA CELLS]]></kwd>
<kwd lng="en"><![CDATA[BLOOD CELLS]]></kwd>
<kwd lng="en"><![CDATA[BONE MARROW]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Moreau]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[San Miguel]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Ludwig]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Schouten]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Mohty]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Dimopoulos]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Multiple Myeloma: ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-up]]></article-title>
<source><![CDATA[Ann Oncol]]></source>
<year>2013</year>
<volume>24</volume>
<numero>^ssupl6</numero>
<issue>^ssupl6</issue>
<supplement>supl6</supplement>
</nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Medina]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Espino]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Blanchard]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Marcadores pronósticos en pacientes con gammapatía monoclonal de significado incierto]]></article-title>
<source><![CDATA[Inmunología]]></source>
<year>201</year>
<volume>33</volume>
<numero>1</numero>
<issue>1</issue>
</nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="book">
<source><![CDATA[Guidelines for the diagnosis and management of multiple myeloma 2014]]></source>
<year>2019</year>
<publisher-name><![CDATA[British Society for Haematology &amp; UK Myeloma Forum]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ramos Ortega]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<source><![CDATA[Incidencia]]></source>
<year>2015</year>
<publisher-loc><![CDATA[España ]]></publisher-loc>
<publisher-name><![CDATA[Sociedad española de Hematología y Hemoterapia. Asociación Española contra el cáncer]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pedroza Vázquez]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Zamora Palma]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Utilidad de pruebas de laboratorio en el diagnóstico de mieloma múltiple]]></article-title>
<source><![CDATA[Rev Latinoam Patol Clin Med Lab]]></source>
<year>2015</year>
<volume>62</volume>
<numero>1</numero>
<issue>1</issue>
</nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Alfonso Hernández]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<source><![CDATA[Mieloma múltiple]]></source>
<year>2018</year>
<publisher-name><![CDATA[La Habana: Consultas Médicas]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bravo García-Morato]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Laboratory guidelines for the diagnosis and follow-up of patients with monoclonal gammopathies]]></article-title>
<source><![CDATA[Rev Clínica Española]]></source>
<year>2016</year>
<volume>216</volume>
<numero>3</numero>
<issue>3</issue>
</nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Calvo Barbado]]></surname>
<given-names><![CDATA[DM]]></given-names>
</name>
<name>
<surname><![CDATA[Delgado Martínez]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
</person-group>
<source><![CDATA[Formulario Nacional de Medicamentos]]></source>
<year>2014</year>
<edition>4ta</edition>
<publisher-loc><![CDATA[La Habana ]]></publisher-loc>
<publisher-name><![CDATA[Ecimed]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[González-Calle]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Fonseca]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Retos y avances hacia la medicina de precisión en el mieloma múltiple]]></article-title>
<source><![CDATA[Medicina (B. Aires)]]></source>
<year>2017</year>
<volume>7</volume>
<numero>(</numero>
<issue>(</issue>
</nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Suárez González]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[González Gil]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[García Menéndez]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Álvarez Vega]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Estrada Vaillant]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Hernández Ugalde]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Comportamiento de las inmunoglobulinas en el seguimiento de pacientes con mieloma múltiple. Hospital Universitario Comandante Faustino Pérez. Matanzas]]></article-title>
<source><![CDATA[Rev Méd Electrón]]></source>
<year>2018</year>
<volume>4</volume>
<numero>(</numero>
<issue>(</issue>
<page-range>69-80</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ramón Rodríguez]]></surname>
<given-names><![CDATA[LG]]></given-names>
</name>
<name>
<surname><![CDATA[Rivera-Keeling]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Arencibia-Núñez]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Caracterización clínica y de laboratorio del mieloma múltiple en el Instituto de Hematología e Inmunología.]]></article-title>
<source><![CDATA[Rev Cubana Hematol Inmunol Hemoter]]></source>
<year>2013</year>
<volume>29</volume>
<numero>4</numero>
<issue>4</issue>
</nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Agreda Pantoja]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Chao Pereira]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Hernández Barraza]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Roca Campaña]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Mieloma múltiple en paciente joven]]></article-title>
<source><![CDATA[Rev cubana med]]></source>
<year>2016</year>
<volume>55</volume>
<numero>4</numero>
<issue>4</issue>
</nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[da Silva Ferreira]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Rafael Maciel]]></surname>
<given-names><![CDATA[JF]]></given-names>
</name>
<name>
<surname><![CDATA[de Souza Rego Pinto Carvalho]]></surname>
<given-names><![CDATA[DP]]></given-names>
</name>
<name>
<surname><![CDATA[Campos de Azevedo]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Fortes Vitor]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Ferreira Júnior]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Clinical characterization and survival of patients with multiple myeloma in a state of northeast brazilian]]></article-title>
<source><![CDATA[Rev Cubana Hematol Inmunol Hemoter]]></source>
<year>2017</year>
<volume>3</volume>
<numero>(</numero>
<issue>(</issue>
</nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="book">
<source><![CDATA[Hematólogos señalan que tratamiento del mieloma múltiple mejora la respuesta antitumoral y tasas de larga supervivencia]]></source>
<year>2018</year>
<publisher-loc><![CDATA[MADRID ]]></publisher-loc>
<publisher-name><![CDATA[FEAD]]></publisher-name>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
